Survivin mRNA Level in Blood Predict the Efficacy of Neoadjuvant Chemotherapy in Patients with Stage IIIA-N2 Non-Small Cell Lung Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Survivin mRNA Level in Blood Predict the Efficacy of Neoadjuvant Chemotherapy in Patients with Stage IIIA-N2 Non-Small Cell Lung Cancer

Published:2014-07-01 Issue:2 Volume:21 Page:257-265
ISSN:1219-4956
Container-title:Pathology & Oncology Research
language:en
Short-container-title:Pathol. Oncol. Res.

Author:

Hu Yi-Ming,Li Jing,Yu Li-Chao,Shi Shun-Bing,Du Yong-Jie,Wu Jian-Nong,Shi Wei Lin

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine,Pathology and Forensic Medicine

Link

http://link.springer.com/content/pdf/10.1007/s12253-014-9816-4.pdf

Reference30 articles.

1. Li J, Dai C-H, Yu L-C et al (2009) Results of trimodality therapy in patients with stage IIIA (N2-Bulky) and stage IIIB non-small cell lung cancer. Clin Lung Cancer 10:353–359

2. Roth JA, Atkinson EN, Fossella F et al (1998) Long-term follow-up of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer. Lung Cancer 21:1–6

3. Stefani A, Alifano M, Bobbio A et al (2010) Which patients should be operated after induction chemotherapy for N2 non-small cell lung cancer? Analysis of a 7 year experience in 175 patients. J Thorac Cardiovase Surg 140:356–363

4. Rosell R, Gomez-Codina J, Camps C et al (1999) Preresectional chemotherapy in stage IIIA non-small-cell lung cancer: a 7-year assessment of a randomized clinical trial. Lung Cancer 26:7–14

5. Depierre A, Milleron B, Moro-Sibilot D et al (2002) Preoperative chemotherapy followed by surgery compared with primary surgery in resectable stage I (except T1N0), II, and IIIa non-small-cell lung cancer. J Clin Oncol 2:247–253

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Expression of Survivin in Squamous Cell Lung Cancer and Its Correlation with Prognosis;International Journal of Hematology and Oncology;2017-12-30

2. Association between survivin genetic polymorphisms and epidermal growth factor receptor mutation in non-small-cell lung cancer;International Journal of Medical Sciences;2016

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3